FDA Inspection 1196982 — AtlantiCare Regional Medical Center IRB

AtlantiCare Regional Medical Center IRB — FEI 1000151271

The FDA completed an inspection of AtlantiCare Regional Medical Center IRB on Feb 10, 2023 in Atlantic City, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 10, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Atlantic City, NJ (United States)

Additional details

IRB

Citations

IDCFRDescription
727821 CFR 56.107(e)Conflict of interest
730421 CFR 56.110(b)(1)No more than minimal risk
731921 CFR 56.115(a)(3)Records of continuing review

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.